November 26, 2020 Only full transparency and rigorous scrutiny of the data will allow for informed decision making, argues Peter Doshi In the United States, all eyes are on Pfizer and Moderna. The topline efficacy results from their experimental covid-19
Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data
